These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36278557)

  • 1. Omicron BA.2.75 Subvariant of SARS-CoV-2 Is Expected to Have the Greatest Infectivity Compared with the Competing BA.2 and BA.5, Due to Most Negative Gibbs Energy of Binding.
    Popovic M
    BioTech (Basel); 2022 Oct; 11(4):. PubMed ID: 36278557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain wars 5: Gibbs energies of binding of BA.1 through BA.4 variants of SARS-CoV-2.
    Popovic M
    Microb Risk Anal; 2022 Dec; 22():100231. PubMed ID: 36034590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
    Parums DV
    Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2.
    Koshikawa T; Miyoshi H
    Biochem Biophys Rep; 2022 Sep; 31():101306. PubMed ID: 35791375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain wars 4 - Darwinian evolution through Gibbs' glasses: Gibbs energies of binding and growth explain evolution of SARS-CoV-2 from Hu-1 to BA.2.
    Popovic M
    Virology; 2022 Oct; 575():36-42. PubMed ID: 36057159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
    Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Never ending story? Evolution of SARS-CoV-2 monitored through Gibbs energies of biosynthesis and antigen-receptor binding of Omicron BQ.1, BQ.1.1, XBB and XBB.1 variants.
    Popovic M
    Microb Risk Anal; 2023 Apr; 23():100250. PubMed ID: 36777740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The First Identification in Italy of SARS-CoV-2 Omicron BA.4 Harboring KSF141_del: A Genomic Comparison with Omicron Sub-Variants.
    Peronace C; Tallerico R; Colosimo M; Fazio M; Pasceri F; Talotta I; Panduri G; Pintomalli L; Oteri R; Calantoni V; Fiorillo MT; Caroleo MC; Curcio R; Dolce V; Cione E; Minchella P
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins.
    Xu Y; Wu C; Cao X; Gu C; Liu H; Jiang M; Wang X; Yuan Q; Wu K; Liu J; Wang D; He X; Wang X; Deng SJ; Xu HE; Yin W
    Cell Res; 2022 Jul; 32(7):609-620. PubMed ID: 35641567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain wars 3: Differences in infectivity and pathogenicity between Delta and Omicron strains of SARS-CoV-2 can be explained by thermodynamic and kinetic parameters of binding and growth.
    Popovic M
    Microb Risk Anal; 2022 Dec; 22():100217. PubMed ID: 35434234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Omicron BA.2 Subvariant of SARS-CoV-2 Outcompetes BA.1 in Two Co-infection Cases.
    Gjorgjievska M; Mehandziska S; Stajkovska A; Pecioska-Dokuzovska S; Dimovska A; Durmish I; Ismail S; Pavlovska T; Stojchevska A; Amedi H; Andonova J; Nikolovska M; Velickovikj S; Mitrev Z; Kungulovski I; Kungulovski G
    Front Genet; 2022; 13():892682. PubMed ID: 35495156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
    Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Microbiol Spectr; 2022 Aug; 10(4):e0136722. PubMed ID: 35861527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 Hydra, a tiny monster from the 21st century: Thermodynamics of the BA.5.2 and BF.7 variants.
    Popovic M
    Microb Risk Anal; 2023 Apr; 23():100249. PubMed ID: 36777924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and high-resolution computed tomography findings of 805 patients with mild or moderate infection from SARS-CoV-2 Omicron subvariant BA.2.
    Pan YN; Gu MY; Mao QL; Ruan XZ; Du XF; Gao X; Chen XQ; Li AJ
    Curr Med Imaging; 2023 Apr; ():. PubMed ID: 37170975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients.
    Deng H; Mai Y; Liu H; Guan J
    Ann Hepatol; 2023; 28(1):100763. PubMed ID: 36182032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS-CoV-2 Omicron BA.1 variant.
    Zhou Z; Du P; Li N; Xiong X; Tang S; Dai Q; Wang T; Yu M; Man M; Lam K; Baptista-Hon DT; Tai WH; Monteiro O; Ng WS; Lee UM; Liu Z; Zhang K; Li G
    MedComm (2020); 2022 Jun; 3(2):e143. PubMed ID: 35592756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia.
    Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Ito T
    Respir Investig; 2024 May; 62(3):384-387. PubMed ID: 38452443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.